Updated Date:
27 Aug 2026
Product Detail:
FOLOTYN pralatrexate 20 mg/1 mL injection, intravenous infusion vial
Shortage Status:
Anticipated
AUST R:
192493
Availability:
Available
Active Ingredient:
pralatrexate
Reason:
Manufacturing
Dosage Form:
Injection,intravenousinfusion
Supply Impact Dates
From 12 Oct 2026
To 06 Nov 2026
Management Action:
The sponsor is closely controlling the supply and working to expedite the next shipment.